MA26828A1 - Derives de purines - Google Patents

Derives de purines

Info

Publication number: MA26828A1
Authority: MA; Morocco
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-10-14

Application number

MA26590A

Other languages

English (en)

Inventor

Marina Monaghan Sandra

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2002-04-09

Publication date

2004-12-20

2002-04-09 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26828A1 publication Critical patent/MA26828A1/fr

Links

229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
150000003212 purines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Gynecology & Obstetrics (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

MA26590A 1999-10-14 2002-04-09 Derives de purines MA26828A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9924363.6A GB9924363D0 (en)	1999-10-14	1999-10-14	Purine derivatives

Publications (1)

Publication Number	Publication Date
MA26828A1 true MA26828A1 (fr)	2004-12-20

Family

ID=10862760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26590A MA26828A1 (fr)	1999-10-14	2002-04-09	Derives de purines

Country Status (50)

Country	Link
US (1)	US6350735B1 (fr)
EP (1)	EP1220863B1 (fr)
JP (1)	JP3994007B2 (fr)
KR (1)	KR20020037774A (fr)
CN (1)	CN1151167C (fr)
AP (1)	AP1442A (fr)
AR (1)	AR023275A1 (fr)
AT (1)	ATE238336T1 (fr)
AU (1)	AU768308B2 (fr)
BG (1)	BG106569A (fr)
BR (1)	BR0011776A (fr)
CA (1)	CA2387531C (fr)
CO (1)	CO5251399A1 (fr)
CR (1)	CR6584A (fr)
CZ (1)	CZ20021223A3 (fr)
DE (1)	DE60002356T2 (fr)
DK (1)	DK1220863T3 (fr)
DZ (1)	DZ3159A1 (fr)
EA (1)	EA004655B1 (fr)
EC (1)	ECSP003712A (fr)
EE (1)	EE200200193A (fr)
ES (1)	ES2193990T3 (fr)
GB (1)	GB9924363D0 (fr)
GE (1)	GEP20043269B (fr)
GT (1)	GT200000172A (fr)
HK (1)	HK1047110B (fr)
HN (1)	HN2000000204A (fr)
HU (1)	HUP0203483A2 (fr)
IL (1)	IL146342A0 (fr)
IS (1)	IS6165A (fr)
MA (1)	MA26828A1 (fr)
MX (1)	MXPA02003812A (fr)
MY (1)	MY136242A (fr)
NO (1)	NO20021692L (fr)
NZ (1)	NZ515323A (fr)
OA (1)	OA12059A (fr)
PA (1)	PA8503501A1 (fr)
PE (1)	PE20010755A1 (fr)
PL (1)	PL354932A1 (fr)
PT (1)	PT1220863E (fr)
SI (1)	SI1220863T1 (fr)
SK (1)	SK4842002A3 (fr)
SV (1)	SV2002000198A (fr)
TN (1)	TNSN00202A1 (fr)
TR (1)	TR200200985T2 (fr)
UA (1)	UA66945C2 (fr)
UY (1)	UY26397A1 (fr)
WO (1)	WO2001027130A1 (fr)
YU (1)	YU88901A (fr)
ZA (1)	ZA200202849B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
CN1535161A (zh) *	2001-05-25	2004-10-06		腺苷A2a受体激动剂和抗胆碱能试剂在联合用药治疗气道阻塞性疾病中的应用
NZ532062A (en) *	2001-10-01	2006-09-29	Univ Virginia	2-propynyl adenosine analogues having A2 adenosine recepter agonist activity and compositions thereof to treat inflammatory responses
EP1496911B1 (fr) *	2002-04-10	2007-12-19	University Of Virginia Patent Foundation	Utilisation d'une combinaison comprenant un agoniste du recepteur d'adenosine a2a et un agent anti-pathogene dans le traitement de maladies inflammatoires
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
US20050033044A1 (en) *	2003-05-19	2005-02-10	Bristol-Myers Squibb Pharma Company	Methods for preparing 2-alkynyladenosine derivatives
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
AU2005267706B2 (en) *	2004-08-02	2011-12-08	University Of Virginia Patent Foundation	2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
US7442687B2 (en) *	2004-08-02	2008-10-28	The University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
US7576069B2 (en) *	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
EP1893593A1 (fr) *	2005-06-15	2008-03-05	Pfizer Limited	Dérivés 3-phénylazétidine comme agonistes de la dopamine
CN100352823C (zh) *	2005-08-19	2007-12-05	浙江车头制药有限公司	一种腺嘌呤衍生物的制备方法
MY144906A (en)	2005-10-21	2011-11-30	Novartis Ag	Human antibodies against il13 and therapeutic uses
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
US20080027022A1 (en) *	2006-02-08	2008-01-31	Linden Joel M	Method to treat gastric lesions
WO2007120972A2 (fr)	2006-02-10	2007-10-25	University Of Virginia Patent Foundation	Procede permettant de traiter l'anemie a hematies falciformes
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
RU2009115954A (ru)	2006-09-29	2010-11-10	Новартис АГ (CH)	Пиразолопиримидины в качестве ингибиторов липидной киназы р13к
JP2010508315A (ja)	2006-10-30	2010-03-18	ノバルティスアーゲー	抗炎症剤としてのヘテロ環式化合物
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
KR20100113557A (ko)	2008-01-11	2010-10-21	노파르티스 아게	키나제 억제제로서의 피리미딘
HRP20121006T1 (hr)	2009-01-29	2013-01-31	Novartis Ag	Supstituirani benzimidazoli za lijeäśenje astrocitoma
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
CA2770873A1 (fr)	2009-08-12	2011-02-17	Novartis Ag	Composes hydrazone heterocycliques et leurs utilisations pour traiter le cancer et l'inflammation
GEP201706639B (en)	2009-08-17	2017-03-27	Intellikine Llc	Heterocyclic compounds and uses thereof
CA2771432A1 (fr)	2009-08-20	2011-02-24	Novartis Ag	Composes d'oximes heterocycliques
WO2012034095A1 (fr)	2010-09-09	2012-03-15	Irm Llc	Composés et compositions comme inhibiteurs de trk
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
JP2014505088A (ja)	2011-02-10	2014-02-27	ノバルティスアーゲー	Ｃ−ＭＥＴチロシンキナーゼ阻害剤としての［１，２，４］トリアゾロ［４，３−ｂ］ピリダジン化合物
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
KR20140014184A (ko)	2011-02-25	2014-02-05	아이알엠 엘엘씨	Trk 억제제로서의 화합물 및 조성물
AU2012310168B2 (en)	2011-09-15	2015-07-16	Novartis Ag	6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase
WO2013078440A2 (fr)	2011-11-23	2013-05-30	Intellikine, Llc	Régimes de traitement améliorés utilisant des inhibiteurs de mtor
EP3964513A1 (fr)	2012-04-03	2022-03-09	Novartis AG	Produits combinés comprenant des inhibiteurs de tyrosine kinase et leur utilisation
WO2014151147A1 (fr)	2013-03-15	2014-09-25	Intellikine, Llc	Combinaison d'inhibiteurs de kinase et ses utilisations
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (fr)	2014-07-25	2016-01-28	Novartis Ag	Polythérapie
BR112017001695A2 (pt)	2014-07-31	2017-11-21	Novartis Ag	terapia de combinação
US12324807B2 (en)	2018-06-01	2025-06-10	Cornell University	Combination therapy for PI3K-associated disease or disorder
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en) *	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
WO1988003147A1 (fr) *	1986-10-31	1988-05-05	Warner-Lambert Company	Adenosines a substitution n6 selectionees ayant une activite de liaison a2 selective
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5877180A (en) *	1994-07-11	1999-03-02	University Of Virginia Patent Foundation	Method for treating inflammatory diseases with A2a adenosine receptor agonists
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
AU5879299A (en) *	1998-10-16	2000-05-08	Monaghan, Sandra Marina	Adenine derivatives

1999
- 1999-10-14 GB GBGB9924363.6A patent/GB9924363D0/en not_active Ceased
2000
- 2000-09-14 HN HN2000000204A patent/HN2000000204A/es unknown
- 2000-09-26 PA PA20008503501A patent/PA8503501A1/es unknown
- 2000-10-06 YU YU88901A patent/YU88901A/sh unknown
- 2000-10-06 UA UA2002042943A patent/UA66945C2/uk unknown
- 2000-10-06 JP JP2001530348A patent/JP3994007B2/ja not_active Expired - Fee Related
- 2000-10-06 IL IL14634200A patent/IL146342A0/xx unknown
- 2000-10-06 HK HK02108605.8A patent/HK1047110B/zh not_active IP Right Cessation
- 2000-10-06 DK DK00964566T patent/DK1220863T3/da active
- 2000-10-06 AT AT00964566T patent/ATE238336T1/de not_active IP Right Cessation
- 2000-10-06 PL PL00354932A patent/PL354932A1/xx not_active Application Discontinuation
- 2000-10-06 TR TR2002/00985T patent/TR200200985T2/xx unknown
- 2000-10-06 HU HU0203483A patent/HUP0203483A2/hu unknown
- 2000-10-06 EE EEP200200193A patent/EE200200193A/xx unknown
- 2000-10-06 AP APAP/P/2002/002478A patent/AP1442A/en active
- 2000-10-06 NZ NZ515323A patent/NZ515323A/en unknown
- 2000-10-06 DZ DZ003159A patent/DZ3159A1/fr active
- 2000-10-06 CZ CZ20021223A patent/CZ20021223A3/cs unknown
- 2000-10-06 ES ES00964566T patent/ES2193990T3/es not_active Expired - Lifetime
- 2000-10-06 AU AU75488/00A patent/AU768308B2/en not_active Ceased
- 2000-10-06 EA EA200101107A patent/EA004655B1/ru not_active IP Right Cessation
- 2000-10-06 SK SK484-2002A patent/SK4842002A3/sk unknown
- 2000-10-06 PT PT00964566T patent/PT1220863E/pt unknown
- 2000-10-06 DE DE60002356T patent/DE60002356T2/de not_active Expired - Fee Related
- 2000-10-06 EP EP00964566A patent/EP1220863B1/fr not_active Expired - Lifetime
- 2000-10-06 GE GEAP20006243A patent/GEP20043269B/en unknown
- 2000-10-06 WO PCT/IB2000/001444 patent/WO2001027130A1/fr not_active Ceased
- 2000-10-06 MX MXPA02003812A patent/MXPA02003812A/es active IP Right Grant
- 2000-10-06 SI SI200030102T patent/SI1220863T1/xx unknown
- 2000-10-06 OA OA1200200102A patent/OA12059A/en unknown
- 2000-10-06 CN CNB008096287A patent/CN1151167C/zh not_active Expired - Fee Related
- 2000-10-06 BR BR0011776-5A patent/BR0011776A/pt not_active IP Right Cessation
- 2000-10-06 KR KR1020027004748A patent/KR20020037774A/ko not_active Abandoned
- 2000-10-06 CA CA002387531A patent/CA2387531C/fr not_active Expired - Fee Related
- 2000-10-12 GT GT200000172A patent/GT200000172A/es unknown
- 2000-10-12 CO CO00077985A patent/CO5251399A1/es not_active Application Discontinuation
- 2000-10-12 MY MYPI20004790A patent/MY136242A/en unknown
- 2000-10-12 EC EC2000003712A patent/ECSP003712A/es unknown
- 2000-10-13 UY UY26397A patent/UY26397A1/es not_active Application Discontinuation
- 2000-10-13 SV SV2000000198A patent/SV2002000198A/es unknown
- 2000-10-13 PE PE2000001098A patent/PE20010755A1/es not_active Application Discontinuation
- 2000-10-13 AR ARP000105421A patent/AR023275A1/es unknown
- 2000-10-13 TN TNTNSN00202A patent/TNSN00202A1/fr unknown
- 2000-10-16 US US09/688,624 patent/US6350735B1/en not_active Expired - Fee Related
2001
- 2001-11-16 IS IS6165A patent/IS6165A/is unknown
2002
- 2002-02-08 CR CR6584A patent/CR6584A/es not_active Application Discontinuation
- 2002-04-02 BG BG106569A patent/BG106569A/xx unknown
- 2002-04-09 MA MA26590A patent/MA26828A1/fr unknown
- 2002-04-10 NO NO20021692A patent/NO20021692L/no not_active Application Discontinuation
- 2002-04-11 ZA ZA200202849A patent/ZA200202849B/xx unknown

Also Published As

Publication number	Publication date
HN2000000204A (es)	2001-06-21
EP1220863A1 (fr)	2002-07-10
CN1151167C (zh)	2004-05-26
GB9924363D0 (en)	1999-12-15
HK1047110B (zh)	2005-03-04
AP2002002478A0 (en)	2002-06-30
CZ20021223A3 (cs)	2003-05-14
JP3994007B2 (ja)	2007-10-17
MXPA02003812A (es)	2002-09-30
SI1220863T1 (en)	2003-10-31
EP1220863B1 (fr)	2003-04-23
DE60002356D1 (de)	2003-05-28
EE200200193A (et)	2003-06-16
DZ3159A1 (fr)	2001-04-19
NZ515323A (en)	2003-10-31
AU7548800A (en)	2001-04-23
PE20010755A1 (es)	2001-07-17
PT1220863E (pt)	2003-07-31
ATE238336T1 (de)	2003-05-15
HK1047110A1 (en)	2003-02-07
MY136242A (en)	2008-08-29
ECSP003712A (es)	2002-05-23
UA66945C2 (uk)	2004-06-15
CA2387531A1 (fr)	2001-04-19
CN1358192A (zh)	2002-07-10
CR6584A (es)	2004-01-14
PL354932A1 (en)	2004-03-22
AR023275A1 (es)	2002-09-04
UY26397A1 (es)	2001-05-31
GEP20043269B (en)	2004-06-25
DE60002356T2 (de)	2004-02-19
HUP0203483A2 (hu)	2003-02-28
AP1442A (en)	2005-06-29
BR0011776A (pt)	2002-03-12
AU768308B2 (en)	2003-12-04
SK4842002A3 (en)	2003-06-03
GT200000172A (es)	2002-04-05
WO2001027130A1 (fr)	2001-04-19
OA12059A (en)	2006-05-03
NO20021692D0 (no)	2002-04-10
ZA200202849B (en)	2003-06-25
SV2002000198A (es)	2002-02-05
CA2387531C (fr)	2006-12-05
BG106569A (en)	2002-12-29
CO5251399A1 (es)	2003-02-28
EA004655B1 (ru)	2004-06-24
US6350735B1 (en)	2002-02-26
JP2003511459A (ja)	2003-03-25
DK1220863T3 (da)	2003-08-11
TR200200985T2 (tr)	2002-10-21
PA8503501A1 (es)	2002-02-21
YU88901A (sh)	2004-09-03
IL146342A0 (en)	2002-07-25
EA200101107A1 (ru)	2002-10-31
KR20020037774A (ko)	2002-05-22
TNSN00202A1 (fr)	2005-11-10
IS6165A (is)	2001-11-16
NO20021692L (no)	2002-04-10
ES2193990T3 (es)	2003-11-16

Publication	Publication Date	Title
MA26829A1 (fr)	2004-12-20	Derives de purines
MA26828A1 (fr)	2004-12-20	Derives de purines
MA26799A1 (fr)	2004-12-20	Derives de purine
MA26918A1 (fr)	2004-12-20	Derives de purine
ATE231874T1 (de)	2003-02-15	Antivirale purin-derivate
ATE325807T1 (de)	2006-06-15	Purinderivate
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
MA26967A1 (fr)	2004-12-20	Derives de pyrimidine
ES1050663Y (es)	2002-08-16	Batidor de purines perfeccionado